Treatment Plan for Psychotherapy
Decision #2:
Treatment Plan for Psychotherapy
Fluvoxamine immediate release 25mg orally daily
Reason for the Selection
Food and Drug Administration authorize fluvoxamine for the treatment of OCD in children eight years and older (Stahl 2014). Fluvoxamine immediate release 25mg orally daily is the medication of choice. Fluvoxamine influences synthetic compounds in the brain that might be uneven in individuals with obsessive-compulsive symptoms. Selective serotonin reuptake inhibitors affect neurotransmitters, chemicals that nerves in the brain use to communicate with each other. Neurotransmitters are released by nerves which travel across the spaces between nerves and then attach to receptors on other nerves.
Patient and family will be educated about the side effects of fluvoxamine which are drowsiness and fatigue, headache, sleeping problems, decreased libido, decreased sexual functioning, gastrointestinal problems, dizziness, nervousness, sweating and tremors. These side effects typically get better after taking the medication for a while (Ordacgi, Mendlowicz, & Fontenelle, 2017).
Cognitive Behavior Therapy (CBT) has proven to be useful in the treatment of OCD. CBT is created on the impression that distorted thoughts or cognitions cause and preserves harmful compulsions and obsessions (Foa, 2017). Exposure and response prevention (ERP) is an active form of behavioral therapy. ERP expose the patient to anxiety that is activated by the obsessions and after that preventing the utilization of rituals to lessen the uneasiness. This cycle of exposure and reaction prevention action is repeated to the point that the patient never again troubled by the fixations as well as impulses (Foa, 2017).
The objective of treatment is complete remission of current indications and additionally aversion of future backslides. Treatment regularly decreases or even eliminates manifestations, however not a fix since signs can repeat after the medication is stopped or therapy not completed.
Expected Result with this Decision
The expectation is that Tyrel will show some sign of improvement from taking the medication when he returns in about four weeks. Fluvoxamine allows serotonin to accumulate; serotonin depletion is thought to obsessions (Ordacgi, Mendlowicz, & Fontenelle, 2017). Tyrel’s mother verbalized that he had been some reduction in his symptoms and that he seemed little relaxes and had decreased handwashing. Tyrel had been able to go out and play with his friend which he had not done for a while. Tyrel seems to be having a little bit of problem embracing school, but his attendance has improved.
Difference between Expected Result and the Achieved Result with Decision #2
There was no difference between the expected outcome and proficient outcome because a low dosage of fluvoxamine was recommended. The patient can result in any case advantage by increasing the medication dose. Thus, it is suitable to increase fluvoxamine dosage at sleep time since the patient is reacting great to treatment administration.